{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:06:45Z","timestamp":1791385605341,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cct.2024.107778","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T17:26:27Z","timestamp":1734110787000},"page":"107778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials"],"prefix":"10.1016","volume":"148","author":[{"given":"Andrea","family":"Bellavia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Zimerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott M.","family":"Antman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2024.107778_bb0005","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(95)90120-5","article-title":"Can overall results of clinical trials be applied to all patients?","volume":"345","author":"Rothwell","year":"1995","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.cct.2024.107778_bb0010","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2024.107778_bb0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.2023.3576","article-title":"Toward personalizing care: assessing heterogeneity of treatment effects in randomized trials","volume":"329","author":"Dahabreh","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2024.107778_bb0020","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1001\/jama.2021.20552","article-title":"Heterogeneity of treatment effect: estimating how the effects of interventions vary across individuals","volume":"326","author":"Angus","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2024.107778_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1745-6215-10-43","article-title":"Dealing with heterogeneity of treatment effects: is the literature up to the challenge?","volume":"10","author":"Gabler","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.cct.2024.107778_bb0030","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2024.107778_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/17407745231171897","article-title":"Overall average treatment effects from clinical trials, one-variable-at-a-time subgroup analyses and predictive approaches to heterogeneous treatment effects: toward a more patient-centered evidence-based medicine","volume":"20","author":"Kent","year":"2023","journal-title":"Clin. Trials (Lond., Engl.)"},{"key":"10.1016\/j.cct.2024.107778_bb0040","first-page":"3","article-title":"Heterogeneity of treatment effect \u2014 an evolution in subgroup analysis","author":"Yarnell","year":"2024","journal-title":"NEJM Evid."},{"key":"10.1016\/j.cct.2024.107778_bb0045","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMp068070","article-title":"The challenge of subgroup analyses \u2014 reporting without distorting","volume":"354","author":"Lagakos","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2024.107778_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.cct.2024.107778_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ahj.2005.04.020","article-title":"Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?","volume":"151","author":"Hern\u00e1ndez","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cct.2024.107778_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/j.pain.0000000000000771","article-title":"Phenotypes and treatment response: it\u2019s difficult to make predictions, especially about the future","volume":"158","author":"Dworkin","year":"2017","journal-title":"PAIN"},{"key":"10.1016\/j.cct.2024.107778_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The predictive approaches to treatment effect heterogeneity (PATH) statement","volume":"172","author":"Kent","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2024.107778_bb0070","first-page":"3","article-title":"Individualized treatment effect prediction with machine learning \u2014 salient considerations","author":"Desai","year":"2024","journal-title":"NEJM Evid."},{"key":"10.1016\/j.cct.2024.107778_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.3376","article-title":"Using effect scores to characterize heterogeneity of treatment effects","author":"Wang","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2024.107778_bb0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.124.069857","article-title":"Heterogeneity of treatment effects in clinical trials: overview of multivariable approaches and practical recommendations","volume":"150","author":"Bellavia","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2024.107778_bb0085","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00134-019-05631-z","article-title":"The use of clustering algorithms in critical care research to unravel patient heterogeneity","volume":"45","author":"Castela Forte","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cct.2024.107778_bb0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1164\/rccm.201807-1346OC","article-title":"Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy","volume":"199","author":"Bhatraju","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2024.107778_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13054-017-1836-5","article-title":"Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness","volume":"21","author":"Seymour","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.cct.2024.107778_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bja.2019.02.026","article-title":"Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"123","author":"Zampieri","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.cct.2024.107778_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103697","article-title":"Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: a secondary analysis of three randomised controlled trials","volume":"74","author":"Sinha","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cct.2024.107778_bb0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00357-016-9211-9","article-title":"Model-based clustering","volume":"33","author":"McNicholas","year":"2016","journal-title":"J. Classif."},{"key":"10.1016\/j.cct.2024.107778_bb0115","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2024.107778_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4198","article-title":"An unsupervised machine learning approach to evaluating the association of symptom clusters with adverse outcomes among older adults with advanced cancer: a secondary analysis of a randomized clinical trial","volume":"6","author":"Xu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cct.2024.107778_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/420134","article-title":"Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities","volume":"2014","author":"Burgel","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cct.2024.107778_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2022.842306","article-title":"Phenotype clustering in health care: a narrative review for clinicians","volume":"5","author":"Loftus","year":"2022","journal-title":"Front. Artif. Intell."},{"key":"10.1016\/j.cct.2024.107778_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cct.2024.107778_bb0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc20-2806","article-title":"Cluster analysis of cardiovascular phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to precision medicine","volume":"45","author":"Sharma","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2024.107778_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cct.2024.107778_bb0150","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/bioinformatics\/bty786","article-title":"VarSelLCM: an R\/C++ package for variable selection in model-based clustering of mixed-data with missing values","volume":"35","author":"Marbac","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cct.2024.107778_bb0155","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11222-016-9670-1","article-title":"Variable selection for model-based clustering using the integrated complete-data likelihood","volume":"27","author":"Marbac","year":"2017","journal-title":"Stat. Comput."},{"key":"10.1016\/j.cct.2024.107778_bb0160","series-title":"Introd. Clust. R","first-page":"3","article-title":"Introduction to clustering","volume":"1","author":"Giordani","year":"2020"},{"key":"10.1016\/j.cct.2024.107778_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2022.101747","article-title":"Latent class cluster analysis: selecting the number of clusters","volume":"9","author":"Lezhnina","year":"2022","journal-title":"MethodsX"},{"key":"10.1016\/j.cct.2024.107778_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006556","article-title":"Recommendations for reporting machine learning analyses in clinical research","volume":"13","author":"Stevens","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.cct.2024.107778_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2021.12.017","article-title":"Edoxaban versus warfarin in high-risk patients with atrial fibrillation: a comprehensive analysis of high-risk subgroups","volume":"247","author":"Gencer","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cct.2024.107778_bb0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1214\/18-AOS1709","article-title":"Generalized random forests","volume":"47","author":"Athey","year":"2019","journal-title":"Ann. Stat."},{"key":"10.1016\/j.cct.2024.107778_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jrsssb\/qkac001","article-title":"Estimating heterogeneous treatment effects with right-censored data via causal survival forests","volume":"85","author":"Cui","year":"2023","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"key":"10.1016\/j.cct.2024.107778_bb0190","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"Assmann","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2024.107778_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer\u2019s guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2024.107778_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0091-7435(87)90082-X","article-title":"The use and abuse of subgroup analysis in epidemiological research","volume":"16","author":"Stallones","year":"1987","journal-title":"Prev. Med."},{"key":"10.1016\/j.cct.2024.107778_bb0205","first-page":"1","article-title":"Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives","volume":"5","author":"Brookes","year":"2001","journal-title":"Health Technol. Assess. (Winch., Engl.)"},{"key":"10.1016\/j.cct.2024.107778_bb0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/humu.22080","article-title":"Deep phenotyping for precision medicine","volume":"33","author":"Robinson","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cct.2024.107778_bb0215","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000372","article-title":"Capturing phenotypes for precision medicine","volume":"1","author":"Robinson","year":"2015","journal-title":"Mol. Case Stud."},{"key":"10.1016\/j.cct.2024.107778_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2020.03.007","article-title":"Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics","volume":"224","author":"Napoli","year":"2020","journal-title":"Am. Heart J."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:27:43Z","timestamp":1736303263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424003616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"alternative-id":["S1551714424003616"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107778","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107778"}}